ID: ALA430100

Max Phase: Preclinical

Molecular Formula: C12H14FNO2

Molecular Weight: 223.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(F)c2c1CC(C)(C)[N+]([O-])=C2

Standard InChI:  InChI=1S/C12H14FNO2/c1-12(2)6-8-9(7-14(12)15)10(13)4-5-11(8)16-3/h4-5,7H,6H2,1-3H3

Standard InChI Key:  QXPWYDUWJNOBMK-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 223.25Molecular Weight (Monoisotopic): 223.1009AlogP: 2.10#Rotatable Bonds: 1
Polar Surface Area: 35.30Molecular Species: ACIDHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: -0.25CX Basic pKa: CX LogP: -0.77CX LogD: 1.25
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.54Np Likeness Score: 0.14

References

1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA.  (1996)  Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides,  (10): [10.1016/0960-894X(96)00181-3]

Source